SPC Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
SPC Financial's XBI Position: Q3 2025 in Review
SPC Financial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.11% in Q3 2025, selling an estimated $721 and leaving 7,286 shares worth $730K. The position accounts for 0.06% of the portfolio, ranked #141.
SPC Financial first reported a position in XBI in Q4 2020 and has held it in 19 quarters since. The position peaked at $2.17M in Q4 2020. 659 funds tracked by Wall St. Rank hold XBI as of Q3 2025.
- SPC Financial held 7,286 shares of State Street SPDR S&P Biotech ETF worth $730K as of Q3 2025.
- SPC Financial sold 8 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $721.
- State Street SPDR S&P Biotech ETF made up 0.06% of SPC Financial's portfolio in Q3 2025, its #141 holding.
- SPC Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 19 quarters since.
- SPC Financial's State Street SPDR S&P Biotech ETF position peaked at $2.17M in Q4 2020.
- 659 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.
Based on SPC Financial's 13F filing for Q3 2025, filed 5 Nov 2025.